Twitter Facebook LinkedIn

News & Events

February 8, 2022 | GSK – SOAR 201818

SOAR 201818 Program
Conducted by GSK
Active: 2014-2016

Countries: Romania, Bulgaria, Croatia, Serbia, Ukraine, Slovak Republic, Russia, Czech Republic, Greece

Primary objective
Data generation for antibiotic resistance of the main community-acquired respiratory tract infection pathogens such as S.pneumoniae and H.influenzae.

Protocol Summary

Isolates collection method:Local labs identify microorganisms based on their routinely used methodology. Then isolates are identified at third party's central laboratory to re-identify microorganisms and perform antibiotic susceptibility testing.
Types of surveillance:Primarily for routine clinical practice, then used for surveillance.
Methodology and breakpoints:Broth microdilution according to CLSI guidelines.
Date Last Updated31-Dec-2016
Contains pediatric data?Yes
Contains genotype data?No
List of publications to be linked Survey of Antibiotic Resistance (SOAR) results 2: respiratory pathogen susceptibility: doi.org/10.1093/jac/dky080
Results from the Survey of Antibiotic Resistance (SOAR) 2014–16 in Bulgaria, Romania, Serbia and Croatia: doi.org/10.1093/jac/dky066
Results from the Survey of Antibiotic Resistance (SOAR) 2014–16 in Russia: doi.org/10.1093/jac/dky065
Results from the Survey of Antibiotic Resistance (SOAR) 2014–16 in the Czech Republic: doi.org/10.1093/jac/dky067
Results from the Survey of Antibiotic Resistance (SOAR) 2014–16 in Ukraine and the Slovak Republic: doi.org/10.1093/jac/dky069
Results from the Survey of Antibiotic Resistance (SOAR) 2014–16 in Greece: doi.org/10.1093/jac/dky068